Patents by Inventor Christopher Creech

Christopher Creech has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CNG3B: a novel cyclic nucleotide-gated cation channel
    Publication number: 20080004430
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG3B, antibodies to CNG3B, methods of detecting CNG3B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. The invention further provides, in a computer system, a method of screening for mutations of human CNG3B genes as well as a method for identifying a three-dimensional structure of human CNG3B polypeptides.
    Type: Application
    Filed: October 23, 2006
    Publication date: January 3, 2008
    Applicant: Icagen, Inc.
    Inventors: Christopher Creech, Timothy Jegla
  • CNG2B: a novel human cyclic nucleotide-gated ion channel
    Publication number: 20060240465
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Application
    Filed: May 24, 2006
    Publication date: October 26, 2006
    Applicant: ICAgen, Inc.
    Inventors: Christopher Creech, Timothy Jegla
  • CNG2B: a novel human cyclic nucleotide-gated ion channel
    Publication number: 20050233371
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 20, 2005
    Applicant: ICAgen, Inc.
    Inventors: Christopher Creech, Timothy Jegla